Ceva Q2 2026: AI licensing momentum drives three-year high revenue
Aug 10, 2026, 7:05 AM EDT2 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Stronger licensing momentum, a meaningful AI platform win, and margin expansion suggest improved profitability and a larger content opportunity, which historically can lift small-cap IP licensors when tied to major customer wins. The NeuPro-M deal and OEM/broad connectivity traction are price-sensitive catalysts that could drive multiple expansion in the near term.
AI summary
What happened, with direct paths to the underlying reporting
Ceva reported Q2 2026 revenue of $29.0 million, up 13% YoY, with licensing and related revenue rising 21% to $18.2 million, a three-year high. The quarter featured ten IP licensing deals, including a NeuPro-M NPU license with a leading global AI platform, and continued connectivity royalty growth. Non-GAAP margins improved to 11% on disciplined cost management, supporting a healthier cash-flow trajectory.
Q2 revenue $29.0M, up 13% YoY. Licensing up 21% to three-year high.
Ten IP licensing deals, including NeuPro-M NPU with AI platform.
Royalty revenue $10.8M, up 1% YoY and 17% sequentially.
Non-GAAP operating income $3.1M; non-GAAP margin 11%.
Ceva device shipments reach 567M units, up 16% YoY.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Italy's tax police have seized €27.4 million from CEVA Logistics due to ongoing investigations into tax fraud and illegal labor practices. This development could signal significan…
CEVA is nearing completion of its Adhishthana cycle, now in Phase 18, which indicates a subdued outlook. This suggests potential weakness in CEVA's stock performance and may lead…
Ceva Animal Health raised €5.5 billion, increasing valuation to €9.2 billion. Bettencourt-Meyers family boosted their stake in Ceva, indicating strong investor confidence.
- CEVA reported a quarterly loss of $0.05 per share, missing estimates. - Revenues for CEVA fell to $22.07 million, missing estimates by 4.27%. - The stock has lost 6.8% year-to-d…